Experienced in IgG4-Related Disease

Dr. Aaron C. Logan

Hematology Oncology | Hematology | Oncology
UCSF Health
Regents Of The University Of California
400 Parnassus Ave, 
San Francisco, CA 
Offers Telehealth
21 Years of Experience

Experienced in IgG4-Related Disease
UCSF Health
Regents Of The University Of California
400 Parnassus Ave, 
San Francisco, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Aaron Logan is a Hematologist Oncology specialist and a Hematologist in San Francisco, California. Dr. Logan has been practicing medicine for over 21 years and is rated as an Experienced provider by MediFind in the treatment of IgG4-Related Disease. His top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Bone Marrow Aspiration, and Bone Marrow Transplant.

His clinical research consists of co-authoring 96 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Hematology Oncology
Hematology
Oncology
Licenses
Internal Medicine in CA
Hospital Affiliations
Ucsf Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alignment Health Plan
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Baylor Scott & White Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Chinese Community Health
  • HMO
  • MEDICARE SNP
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

HMSA
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Sutter Health
  • HMO
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Western Health Advantage
  • HMO
  • INSURANCE PLAN
  • MEDICARE DISCOUNT CARD
  • MEDICARE MAPD
View 16 Less Insurance Carriers -

Locations

REGENTS OF THE UNIVERSITY OF CALIFORNIA
400 Parnassus Ave, San Francisco, CA 94143
Call: 415-476-4029
Other Locations
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
2330 Post St, San Francisco, CA 94115
Call: 415-476-4029

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


3 Clinical Trials

An Open-Label, Multi-Centre, Phase Ib/II Study Evaluating the Safety and Efficacy of AUTO1, a CAR T Cell Treatment Targeting CD19, in Adult Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukaemia
An Open-Label, Multi-Centre, Phase Ib/II Study Evaluating the Safety and Efficacy of AUTO1, a CAR T Cell Treatment Targeting CD19, in Adult Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukaemia
Enrollment Status: Active_not_recruiting
Publish Date: September 09, 2025
Intervention Type: Biological
Study Drugs: Cyclophosphamide, Fludarabine, CD19-Positive CAR-T Cells
Study Phase: Phase 1/Phase 2
Phase 1b Trial of the Combination of Ibrutinib and Azacitidine for the Treatment of Higher Risk Myelodysplastic Syndromes in Previously Treated Patients or in Untreated Patients Unfit for or Who Refuse Intense Therapy
Phase 1b Trial of the Combination of Ibrutinib and Azacitidine for the Treatment of Higher Risk Myelodysplastic Syndromes in Previously Treated Patients or in Untreated Patients Unfit for or Who Refuse Intense Therapy
Enrollment Status: Completed
Publish Date: October 06, 2022
Intervention Type: Drug
Study Drugs: Azacitidine, Ibrutinib
Study Phase: Phase 1
A Phase 1, First in Human, Open Label, Dose Escalation Study of AMV564, a CD33 x CD3 Tandem Diabody in Patients With Relapsed or Refractory Acute Myeloid Leukemia
A Phase 1, First in Human, Open Label, Dose Escalation Study of AMV564, a CD33 x CD3 Tandem Diabody in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Enrollment Status: Completed
Publish Date: October 12, 2021
Intervention Type: Biological, Combination product
Study Drugs: AMV564, Pembrolizumab
Study Phase: Phase 1
View 2 Less Clinical Trials

96 Total Publications

Hematopoietic Cell Transplantation, Version 3.2025, NCCN Clinical Practice Guidelines In Oncology.
Hematopoietic Cell Transplantation, Version 3.2025, NCCN Clinical Practice Guidelines In Oncology.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: October 09, 2025
View All 96 Publications
Similar Doctors
Experienced in IgG4-Related Disease
Dr. Elizabeth A. Odumakinde
Hematology Oncology | Hematology | Oncology
Experienced in IgG4-Related Disease
Dr. Elizabeth A. Odumakinde
Hematology Oncology | Hematology | Oncology

John Muir Physician Network

2571 Park Ave, 
Concord, CA 
 (27.7 miles away)
925-674-2100
Experience:
43+ years
Languages Spoken:
English, Yoruba
See accepted insurances

Elizabeth Odumakinde is a Hematologist Oncology specialist and a Hematologist in Concord, California. Dr. Odumakinde has been practicing medicine for over 43 years and is rated as a Distinguished provider by MediFind in the treatment of IgG4-Related Disease. Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Familial Colorectal Cancer, and Small Lymphocytic Lymphoma (SLL).

Experienced in IgG4-Related Disease
Dr. Rajesh Behl
Hematology Oncology | Hematology | Oncology
Experienced in IgG4-Related Disease
Dr. Rajesh Behl
Hematology Oncology | Hematology | Oncology

Epic Care

1480 64th St, Suite 100, 
Emeryville, CA 
 (10.6 miles away)
510-629-6682
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Rajesh Behl is a Hematologist Oncology specialist and a Hematologist in Emeryville, California. Dr. Behl is rated as a Distinguished provider by MediFind in the treatment of IgG4-Related Disease. His top areas of expertise are Waldenstrom Macroglobulinemia, Monoclonal Gammopathy of Undetermined Significance (MGUS), Schnitzler Syndrome, Multiple Myeloma, and Bone Marrow Aspiration.

Experienced in IgG4-Related Disease
Dr. Arpeet T. Shah
Oncology | Hematology | Hematology Oncology
Experienced in IgG4-Related Disease
Dr. Arpeet T. Shah
Oncology | Hematology | Hematology Oncology

Stanford Health Care

300 Pasteur Dr, 
Stanford, CA 
 (27.6 miles away)
650-723-4000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Arpeet Shah is an Oncologist and a Hematologist in Stanford, California. Dr. Shah is rated as an Advanced provider by MediFind in the treatment of IgG4-Related Disease. His top areas of expertise are Childhood Iron Deficiency Anemia, Iron Deficiency Anemia, Blood Clots, Thrombocytopenia, and Nephrectomy.

VIEW MORE IGG4-RELATED DISEASE DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Logan's expertise for a condition
ConditionClose
  • Elite
  • Acute Lymphoblastic Leukemia (ALL)
    Dr. Logan is
    Elite
    . Learn about Acute Lymphoblastic Leukemia (ALL).
    See more Acute Lymphoblastic Leukemia (ALL) experts
  • Distinguished
  • Acute Myeloblastic Leukemia with Maturation
    Dr. Logan is
    Distinguished
    . Learn about Acute Myeloblastic Leukemia with Maturation.
    See more Acute Myeloblastic Leukemia with Maturation experts
  • Acute Myeloblastic Leukemia without Maturation
    Dr. Logan is
    Distinguished
    . Learn about Acute Myeloblastic Leukemia without Maturation.
    See more Acute Myeloblastic Leukemia without Maturation experts
  • Acute Myeloid Leukemia (AML)
    Dr. Logan is
    Distinguished
    . Learn about Acute Myeloid Leukemia (AML).
    See more Acute Myeloid Leukemia (AML) experts
  • Childhood Acute Myeloid Leukemia
    Dr. Logan is
    Distinguished
    . Learn about Childhood Acute Myeloid Leukemia.
    See more Childhood Acute Myeloid Leukemia experts
  • Chronic Graft Versus Host Disease (cGvHD)
    Dr. Logan is
    Distinguished
    . Learn about Chronic Graft Versus Host Disease (cGvHD).
    See more Chronic Graft Versus Host Disease (cGvHD) experts
  • Graft Versus Host Disease (GvHD)
    Dr. Logan is
    Distinguished
    . Learn about Graft Versus Host Disease (GvHD).
    See more Graft Versus Host Disease (GvHD) experts
View All 11 Distinguished Conditions
  • Advanced
  • Acute Monoblastic Leukemia (AmoL)
    Dr. Logan is
    Advanced
    . Learn about Acute Monoblastic Leukemia (AmoL).
    See more Acute Monoblastic Leukemia (AmoL) experts
  • Acute Promyelocytic Leukemia
    Dr. Logan is
    Advanced
    . Learn about Acute Promyelocytic Leukemia.
    See more Acute Promyelocytic Leukemia experts
  • Adult T-Cell Leukemia
    Dr. Logan is
    Advanced
    . Learn about Adult T-Cell Leukemia.
    See more Adult T-Cell Leukemia experts
  • Aplastic Anemia
    Dr. Logan is
    Advanced
    . Learn about Aplastic Anemia.
    See more Aplastic Anemia experts
  • Bone Marrow Aspiration
    Dr. Logan is
    Advanced
    . Learn about Bone Marrow Aspiration.
    See more Bone Marrow Aspiration experts
  • Bone Marrow Transplant
    Dr. Logan is
    Advanced
    . Learn about Bone Marrow Transplant.
    See more Bone Marrow Transplant experts
View All 24 Advanced Conditions
  • Experienced
  • Acute Myelomonocytic Leukemia
    Dr. Logan is
    Experienced
    . Learn about Acute Myelomonocytic Leukemia.
    See more Acute Myelomonocytic Leukemia experts
  • Agranulocytosis
    Dr. Logan is
    Experienced
    . Learn about Agranulocytosis.
    See more Agranulocytosis experts
  • Anaplastic Large Cell Lymphoma
    Dr. Logan is
    Experienced
    . Learn about Anaplastic Large Cell Lymphoma.
    See more Anaplastic Large Cell Lymphoma experts
  • Ataxia-Pancytopenia Syndrome
    Dr. Logan is
    Experienced
    . Learn about Ataxia-Pancytopenia Syndrome.
    See more Ataxia-Pancytopenia Syndrome experts
  • B-Cell Lymphoma
    Dr. Logan is
    Experienced
    . Learn about B-Cell Lymphoma.
    See more B-Cell Lymphoma experts
  • Burkitt Lymphoma
    Dr. Logan is
    Experienced
    . Learn about Burkitt Lymphoma.
    See more Burkitt Lymphoma experts
View All 62 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2025 All Rights Reserved